Target intelligence / Profile preview

Nanog homeobox pseudogene 9 (NANOGP9)

Target
NANOGP9
Molecular classification
Other (pseudogene)
01

Overview

Nanog homeobox pseudogene 9 (NANOGP9) is classified as a **pseudogene** within the NANOG homeobox gene family. Pseudogenes are segments of DNA that resemble functional genes but are generally considered nonfunctional due to mutations that prevent them from encoding active proteins[2][8][9]. NANOGP9, located on the X chromosome at Xq12, is one of several NANOG-related pseudogenes in the human genome[2]. Unlike the functional NANOG gene—which encodes a homeobox transcription factor critical for the maintenance of pluripotency in embryonic stem cells—NANOGP9 does **not** produce a functional protein and does not play a direct role in biological processes, disease, or drug interactions[2][8][9]. Notes on correctness: - NANOGP9 is not a direct therapeutic target, nor does it encode an active transcription factor[8][9][2]. - While some NANOG pseudogenes (e.g., NANOGP8) may be transcribed and have rare roles in cancer biology, there is no evidence to support a functional or pathological role for NANOGP9[9]. - Pseudogenes may, in rare circumstances, be co-opted for regulatory or other functions, but no such data exist for NANOGP9. Summary: NANOGP9 is a noncoding pseudogene, not a functional molecular target or a gene of current therapeutic, diagnostic, or biomarker interest[2][8][9].

Other names
NANOGP6

Beyond the preview

Go deeper on Nanog homeobox pseudogene 9 (NANOGP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanog homeobox pseudogene 9 (NANOGP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call